EX-99.2 3 d385879dex992.htm EX-99.2 EX-99.2

Exhibit 99.2

 

LOGO

16 November 2022

Market Announcements Office

Australian Securities Exchange Limited

20 Bridge Street

SYDNEY NSW 2000

Dear Ms,

Results of 2022 Annual General Meeting

Opthea Limited (ASX: OPT)

In accordance with Listing Rule 3.13.2 and section 251AA of the Corporations Act, we advise details of the resolutions and the proxies received in respect of each resolution are set out in the attached proxy summary.

Yours faithfully

 

LOGO

Karen Adams

Company Secretary

 

 

Opthea Limited, Suite 0403, Level 4, 650 Chapel Street, South Yarra, Victoria  3141, Australia

A.C.N. 006 340 567 l Telephone: +61 3 9826 0399 l Website: www.opthea.com


Opthea Limited

Annual General Meeting

Wednesday, 16 November 2022

Results of Meeting

 

   LOGO

 

 

The following information is provided in accordance with section 251AA(2) of the Corporations Act 2001 (Cth) and ASX Listing Rule 3.13.2.

 

Resolution details

  Instructions given to validly appointed proxies
(as at proxy close)
  Number of votes cast on the poll
(where applicable)
  Resolution
Result

Resolution

  Resolution
Type
  For   Against   Proxy’s
Discretion
  Abstain   For   Against   Abstain*   Carried /
Not Carried

1 Re-Election of Director - Dr Jeremy Levin

  Ordinary   167,252,026
75.28%
  53,023,618
23.87%
  1,878,047
0.85%
  374,076   169,131,253
76.13%
  53,023,618
23.87%
  374,076   Carried

2 Re-Election of Director - Mr Daniel Spiegelman

  Ordinary   219,810,263
98.95%
  459,781
0.20%
  1,878,047
0.85%
  379,676   221,689,490
99.79%
  459,781
0.21%
  379,676   Carried

3 Re-Election of Director - Dr Julia Haller

  Ordinary   219,689,121
98.89%
  586,323
0.26%
  1,878,247
0.85%
  374,076   221,568,538
99.74%
  586,323
0.26%
  374,076   Carried

4 Adoption of remuneration report

  Ordinary   177,830,242
82.05%
  38,527,716
17.78%
  356,683
0.17%
  363,664   178,188,095
82.22%
  38,527,726
17.78%
  363,664   Carried

5 Issue of options to Mr Lawrence Gozlan under the non-executive director share and option plan

  Ordinary   166,753,612
75.51%
  53,738,764
24.34%
  325,237
0.15%
  100,090   167,080,019
75.66%
  53,738,774
24.34%
  100,090   Carried

6 Issue of options to Mr Daniel Spiegelman under the NED Plan

  Ordinary   171,936,437
77.30%
  48,557,739
21.83%
  1,933,501
0.87%
  100,090   172,261,044
78.01%
  48,557,739
21.99%
  100,090   Carried

7 Issue of options to Mr Michael Sistenich under the NED Plan

  Ordinary   166,772,584
74.98%
  53,723,092
24.15%
  1,932,001
0.87%
  100,090   167,095,691
75.67%
  53,723,102
24.33%
  100,090   Carried

8 Issue of options to Dr Megan Baldwin under the long term incentive plan

  Ordinary   163,234,536
74.67%
  53,423,472
24.44%
  1,932,001
0.89%
  98,360   163,557,643
75.38%
  53,423,472
24.62%
  98,360   Carried

9 Approval of issue of performance rights awarded to Dr Megan Baldwin under the LTIP

  Ordinary   159,952,205
73.17%
  56,714,799
25.94%
  1,934,001
0.89%
  87,364   160,277,312
73.86%
  56,714,809
26.14%
  87,364   Carried

10 Approval of issue of performance rights awarded to Mr Lawrence Gozlan under the NED Plan

  Ordinary   166,767,044
75.51%
  53,746,328
24.34%
  326,179
0.15%
  78,152   167,094,393
75.66%
  53,746,338
24.34%
  78,152   Carried

11 Approval of issue of performance rights awarded to Mr Daniel Spiegelman under the NED Plan

  Ordinary   166,791,316
74.98%
  53,726,298
24.15%
  1,932,001
0.87%
  78,152   167,114,423
75.67%
  53,726,308
24.33%
  78,152   Carried

 

*

Votes cast by a person who abstains on an item are not counted in calculating the required majority on a poll.

 

1/1